COMMUNIQUÉS West-GlobeNewswire

Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture
13/03/2018
Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) today publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger [...]
Shire Applies to Cease to be a Reporting Issuer in Canada
13/03/2018
Shire Applies to Cease to be a Reporting Issuer in Canada Dublin, Ireland - 13 March 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company") announces that it has applied to the Autorité des marchés [...]
Immuron Progresses Discussions with Institutional Funds
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
Gemphire Therapeutics to Announce Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15
13/03/2018
LIVONIA, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
TrustedHealth Launches Global Network for Treatment of Life-Threatening Diseases, Presenting at World Health Organization
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- TrustedHealth , a blockchain-based patient and doctor-centric health ecosystem in specialized medicine, is launching to increase access to condition-specific specialists [...]
Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
13/03/2018
Completes Sale of Hyperimmune Commercial Business for up to $74.5 Million Forms Strategic Bispecific Antibody Partnership with Alligator Bioscience Demonstrating Versatility of the ADAPTIR™ Technology Platform Advances [...]
NSS Labs Initiates Group Test Coverage of the Endpoint Detection and Response Market
13/03/2018
AUSTIN, Texas, March 13, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that it is expanding on its strong foundation of [...]
Predictive Technology Group Announces Presentations of Clinical Research Relating to the Role of Genetics in Endometriosis at the Society for Reproductive Investigation Meeting
13/03/2018
SALT LAKE CITY, March 13, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED), a life-sciences technology company, today announces new clinical data relating to the role of genetics in the [...]
Exalenz Bioscience’s BreathID® Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
13/03/2018
MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN ), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]
Tabula Rasa HealthCare Chief Pharmacotherapy Officer Robert L. Alesiani to Receive American Pharmacists Association’s Hugo H. Schaefer Award
13/03/2018
MOORESTOWN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc ., (“TRHC”) (NASDAQ: TRHC ) announced today that Chief Pharmacotherapy Officer Robert L. Alesiani, PharmD, BCGP, has been named the 2018 [...]
Precipio Settles Lawsuit with Crede Capital
13/03/2018
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO ), announced today it has settled its lawsuit with Crede Capital Group LLC, restructuring the final [...]
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
13/03/2018
MINNEAPOLIS, March 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]
Hydropothecary bolsters management team in preparation for recreational cannabis
13/03/2018
GATINEAU, Quebec, March 13, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX Venture:THCX) (“Hydropothecary”) is pleased to announce the addition of three new members to its management team. Roch [...]
Hydropothecary renforce son équipe de direction en vue de la légalisation du cannabis à fins récréatives
13/03/2018
GATINEAU, Québec, 13 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary ») a le plaisir d’annoncer l’arrivée de trois nouveaux cadres dans son équipe de direction. Roch [...]
Richard T. Schumacher, CEO of Pressure BioSciences, Inc., Returns to Uptick Newswire's "Stock Day" Podcast with Everett Jolly to Review Significant Achievements in 2017 and Discuss Exciting Developments Expected in 2018
13/03/2018
Phoenix, March 13, 2018 (GLOBE NEWSWIRE) -- Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly [...]
Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
13/03/2018
TUSTIN, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin
13/03/2018
13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ID Kit and platform begin Decentralised molecular HCV assays shipped to Africa genedrive plc (AIM: GDR), the near patient [...]
Healthwise and GetWellNetwork Partner to Deliver Award-Winning Health Education
13/03/2018
BOISE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- Healthwise and GetWellNetwork ® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over [...]
CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Pages